Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Share-based Compensation (2022 - 2025)

Moolec Science (MLECW) posted Share-based Compensation of $7.3 million for Q4 2025, little changed sequentially from $7.3 million in Q2 2025, and up 258.21% YoY from $2.0 million in Q4 2024.

Moolec Science (MLECW) Share-based Compensation (2022 - 2025) Analysis & Trends

Moolec Science has reported Share-based Compensation for 4 years, with the latest figure at $7.3 million in Q4 2025.

  • Quarterly Share-based Compensation rose 258.21% year-over-year to $7.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.3 million (up 258.21% YoY) and the FY2025 annual result came in at $7.3 million, down 48.79% from the prior year.
  • Share-based Compensation was little changed at $7.3 million in Q4 2025 per MLECW's latest filing, from $7.3 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $15.9 million in Q2 2024 and troughed at -$323.0 in Q1 2023.
  • A 4-year average of $3.6 million and a median of $2.2 million in 2023 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2023 and 2024: Share-based Compensation slumped 100.45% in 2023, then surged 920074.61% in 2024.
  • Over 4 years, Share-based Compensation stood at $551841.0 in 2022, then soared by 298.92% to $2.2 million in 2023, then fell by 7.34% to $2.0 million in 2024, then jumped by 258.21% to $7.3 million in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $7.3 million, $7.3 million, and $2.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 120.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 137.41 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 86.63 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 28.05 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 41.25 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.31 Mn
Dec 31, 2025 7.31 Mn
Jun 30, 2025 7.27 Mn
Jun 30, 2025 7.27 Mn
Dec 31, 2024 2.04 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 3.67 Mn
Sep 30, 2024 3.67 Mn
Jun 30, 2024 15.91 Mn
Jun 30, 2024 15.91 Mn
Mar 31, 2024 2.97 Mn
Mar 31, 2024 2.97 Mn
Dec 31, 2023 2.20 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 1.74 Mn
Sep 30, 2023 1.74 Mn
Jun 30, 2023 3.56 Mn
Jun 30, 2023 3.56 Mn
Mar 31, 2023 -323.00
Mar 31, 2023 -323.00